Familial hypercholesterolemia (FH) is severely underdiagnosed in the USA; yet, factors influencing family notification about risk for FH in the US pediatric setting have not been well elucidated. Most previous research on these factors has occurred in adult patient populations in European countries with organized cascade screening programs; therefore, we sought to characterize parent experiences with cascade screening in the US pediatric setting. A quantitative survey measuring family notification of FH risk information was administered to 38 parents of children with FH identified within a pediatric cardiology clinic. Participants were also asked if family notification was impacted by intrapersonal, interpersonal, institutional, community, and public policy factors identified previously in other populations. Notification of at least one of the proband's living grandparents or aunts/uncles was reported by 76% (n = 25/33) and 71% (n = 24/34) of participants, respectively. The most common reason for notification was to protect relatives from heart disease. Two of the most common reasons participants did not notify relatives were a lack of information about FH and concern that the relative would have difficulty understanding the information. Yet, only a minority of participants (39%) accessed institutional resources such as educational materials to share with relatives or assistance drafting a family letter that could address these barriers. Based on the identified barriers and motivators for family communication, we suggest facilitators to improve implementation of cascade screening.
Introduction
Familial hypercholesterolemia (FH) is a disease of high levels of low-density lipoprotein C (LDL-C) with autosomaldominant inheritance that predisposes individuals to premature cardiovascular disease (CVD) (Austin et al. 2004; Gidding et al. 2015; Stone et al. 1974 ). Incidence of FH is estimated at 1:250 (Benn et al. 2012; De Ferranti et al. 2016; Pang et al. 2016) . Treatment with lipid-lowering drugs and lifestyle modifications can lower CVD risk for adults (Versmissen et al. 2008) . In children with FH, some evidence indicates statin therapy can slow carotid intima-media thickness (cIMT) progression, which is a marker of atherosclerosis (Kusters et al. 2014; Wiegman et al. 2004 ).
Detection of FH cases early in life is therefore optimal and can be facilitated by universal and/or cascade screening. The US National Heart, Lung, and Blood Institute recommends universal lipid screening for children aged 9-11 (NHLBI 2011) . Cascade screening of first, second, and third degree relatives who are at hereditary risk has also been recommended by the US Centers for Disease Control and Prevention (CDC 2014; George et al. 2015 ). Yet, no nationwide population or cascade screening program currently exists, and the diagnosis rate for FH in the US is estimated to be < 1% of expected cases (Gonzalez Santos and Underberg 2011; Nordestgaard et al. 2013) . Even when a pediatric FH case is identified, one study in a US pediatric clinic reported an average of only 1.5 relatives diagnosed per index case (Stempel et al. 2016) ; in the Netherlands, that average was 8 (Defesche 2010) .
One way to increase the FH diagnosis rate in the USA would be to increase the number of relatives screened per index case (Morris et al. 2012) . In order to optimize practice interventions to increase the extent of cascade screening in pediatric cases, data are needed on the current motivators and barriers to family notification. Most previous research on these factors has occurred in adult patient populations in European countries with organized cascade screening programs that do not exist in the USA. For example, in the Netherlands' 20-year cascade program, at-risk relatives were contacted by health care providers (direct cascade), while in the USA, relatives are typically contacted by the index case or another relative (indirect cascade) (Allison 2015; Newson and Humphries 2005) . To address this research need, in the present study, we evaluated factors influencing family notification of FH risk in a large pediatric lipid clinic in the USA (n = 127). Our sample and the results of this research represent a considerable percentage of the reported cases in the US when compared with the national CascadeFH™ registry which has3 50 total pediatric cases (Amrock et al. 2017 ).
Patients and Methods
Design Study procedures were approved by the University of Minnesota Institutional Review Board. A cross-sectional study collected data from parents of a child with FH. A survey was designed to assess themes identified in previous studies of FH patient and family experiences and was informed by the framework of intrapersonal (existing within a person), interpersonal (relationships between people), institutional, and community/public policy domains described by van den Nieuwenhoff et al. (van den Nieuwenhoff et al. 2007 ) that are hypothesized to influence notification of risk information. The 44-item survey was administered online via Qualtrics research software or self-administered by paper survey. Participants were asked whether their child with FH has any living grandparents or aunts/uncles who have been notified about FH risk (i.e., risk for having FH and associated cardiovascular risks) by the participant, someone else, or no one. Other requested clinical information included: a diagnosis of FH for the child's mother and/or father; FH testing for the child's siblings, grandparents, and aunts/uncles; use of cholesterol-lowering drugs by the child; and adherence to preventative behaviors (healthy diet and physical activity). Possible barriers and facilitators to family notification from the intrapersonal, interpersonal, institutional, and community/public policy domains were assessed with response options of yes/no. Socioeconomic data gathered included parents' gender, age, race and/or ethnicity, education, marital status, and health insurance status. Three health care providers working in cardiology clinics as well as with four parents from the general public piloted the survey using a talk-aloud procedure in which the first author took notes and responded to concerns during the survey completion. Modifications were made to the survey based on the piloting results.
Participants
Recruitment occurred through a database of pediatric patients with a clinical diagnosis of FH who have been seen at the University of Minnesota Pediatric Cardiology clinic since December 1999 and who were consented for research (n = 127 households). An invitation packet was mailed to all households. Participants were eligible if they were the biological parent of pediatric patient with a clinical diagnosis of FH. Parents were excluded if there was no known biological family history and if the individual could not read English. The invitation packet included a description of the purpose of the study, the investigators' contact information, a consent form, the web address of the survey, a paper copy of the survey, and a stamped pre-addressed envelope. Reminder phone calls were made to households 2 weeks following the paper mailing. Responses were gathered from August to November 2016. Participants could provide a name and mailing address to collect a financial incentive that was offered for survey completion (a US$10 Visa gift card). Only one response was counted per household. Identifying information was removed from the returned surveys before data analysis. Data from paper surveys were entered into the online form by one of the authors, and all responses were audited by a second researcher.
Data Analysis
Calculation of summary statistics and drawing of plots were performed using R, version 3.2. Exploratory statistical tests were conducted to analyze differences between families with notification (those with at least one grandparent or aunt/uncle who had been notified) and families without known notification for responses to other survey items using Fisher's exact tests and t tests as appropriate.
Results

Sample Characteristics
Of 127 households invited to participate in the survey, there were 38 unique responses and 4 invitations returned to sender as undeliverable (31% response rate). All unique responses were included in data analysis, as all participants completed > 85% of the items. Since the number of responses differed by question, denominators are included for each. Parental participants had a mean age (± standard deviation) of 48 ± 11 years. Most were female (87%), white (92%), had a college degree or higher (71%), were married or in a marriagelike relationship (74%), and had private health insurance (74%) ( Table 1) . For comparison, in the 2015 Minnesota census, individuals were 50% female, 85% white, 33% college graduates or higher, and 56% of individuals 15 years or older were married (BUnited States Census Bureau Family and Living Arrangements: State Tables^2000, BUnited States Census Bureau Quick Facts: Minnesota^2015).
Participants were asked for the reason(s) their child with FH (the proband) was originally tested. Most reported a recommendation from doctor or other health care provider (63%). Some participants reported parent request (42%), suggestion from other family members due to family history of high cholesterol (26%), or not knowing the reason for testing (5%).
Half of the probands (50%) were reported to use cholesterol-lowering drugs, and most participants (87%) reported ensuring that their child eats healthily and has sufficient physical activity every day.
Most participants preferred indirect over direct cascade screening. Sixty-eight percent of participants preferred that they contact family members about the risk of FH, 5% preferred that a healthcare provider directly contact family members, and 26% had no preference. No participants said indirect notification would be a violation of privacy.
Previous FH Testing (Cholesterol Screening) of Parents and Siblings of the Proband
Seventy-six percent of probands (n = 29/38) were reported to have a mother and/or father who has been diagnosed with FH via cholesterol screening, clinical exam, and family history assessment by a health care provider. Testing was positive for 56% of parents (n = 37/66) who were tested. Neither parent had been tested for 8% of probands (n = 3/38), both had tested negative for 8% (n = 3), testing status of both parents was unknown for 3% (n = 1), and the remaining 5% (n = 2) had one parent test negative while the testing status of the other parent was unknown. Testing of siblings was reported for 71% of families (n = 22/31), no testing had occurred for 23% (n = 7), and testing status was unknown for 6% (n = 2) ( Fig. 1 ).
Notification and FH Testing of Grandparents and Aunts/Uncles of the Proband
Notification of at least one of the proband's living grandparents was reported by 76% (n = 25/33), 12% (n = 4) said no notification had occurred, and 12% (n = 4) did not know whether notification had occurred (Fig. 2 ). Within the families where notification of grandparents was reported, 10 participants (40%) had been the only person to notify the grandparent(s), 9 participants (36%) said someone else had been the only person to notify the grandparent(s), and 6 participants (24%) said they and someone else had performed the notification. FH testing had occurred for at least one grandparent in 75% of families (n = 24/32), 19% of participants (n = 6) did not know whether the proband's grandparents had been tested, and no grandparents had been tested in 6% of families (n = 2) ( Fig. 1) .
Notification of at least one of the proband's living aunts or uncles was reported by 71% (n = 24/34), 9% (n = 3) said no notification had occurred, and 21% (n = 7) did not know whether notification had occurred (Fig. 2) . Within the families where notification of aunt(s)/uncle(s) was reported, 9 participants (26%) had been the only person to notify the aunt(s)/ uncle(s), 12 participants (35%) said someone else had been the only person to notify the aunt(s)/uncle(s), and 3 participants (9%) said that they and someone else had performed the notification. FH testing had occurred for at least one aunt/ uncle in 61% of families (n = 19/31), 32% of participants (n = 10) did not know whether the proband's aunt(s)/uncle(s) had been tested, and no aunts/uncles had been tested in 6% of families (n = 2) ( Fig. 1 ).
Intrapersonal and Interpersonal Factors
Participants were asked about certain intrapersonal factors as reasons they did or did not notify a family member that they could be at risk of FH (Table 2) . Participants could select more than one reason; therefore, values do not total 100%. Fiftyeight percent reported feeling a moral obligation as a reason for notifying a family member in the past. No participants said that feeling an absence of personal responsibility prevented notification. The most common reason for not notifying family members was that the participant did not have enough understanding of FH to accurately discuss the information (11%). Similarly, 11% of participants said they had not notified family members because the other family members would have difficulty understanding the information.
Most participants identified interpersonal factors as motivating their past decision to notify a family member ( Table 2) . The most prevalent reason endorsed by participants for family notification was to protect relatives from heart disease (87%). Consistent with this motivation, almost all participants understood that FH leads to risk of heart disease. Specifically, 92% accurately answered the following knowledge question: Based on a diagnosis of FH, a person who is not treated has a higher (rather than lower or equal) risk of developing coronary artery disease in his/her lifetime compared to an average person without FH.
Another prevalent reason for notification was to allow family members to make changes in lifestyle (76%). This concept also underlies one of the top reasons given for not notifying family members: family members would not care enough to make changes in lifestyle (11%). The risk of heart disease as well as preventative lifestyle modifications could lead to changes in quality of life. Therefore, participants were asked if they are concerned about a possible change in quality of life for themselves and/or family members based on the familial risk for FH. Sixteen participants (42%) agreed that they had this concern.
A less common reason for notification was because the participant needed emotional support from family members for their child's FH (18%). Other reasons given for not notifying family members included not being in contact with some family members (8%), family members who would Fig. 2 Notification of relatives. Probands are separated into those with at least one grandparent or aunt/uncle who was notified about FH risk only by the survey participant (the proband's parent), notified only by someone else, notified both by the survey participant and someone else, not notified by anyone, or unknown notification status. Categories are mutually exclusive and sum to 1. Some participants did not answer these questions, possibly because that proband does not have certain relatives Fig. 1 FH testing of relatives. Probands are separated into those with at least one sibling, grandparent, or aunt/uncle who was tested for FH, those with a mix of tested and untested relatives, those with no tested relatives, or those with relatives of unknown testing status. Categories are mutually exclusive and sum to 1. Some participants did not answer these questions, possibly because that proband does not have certain relatives not want to hear about FH risk (5%), difficulty finding a time to communicate (3%), and wanting to protect family members from emotional distress (3%).
Institutional Factors
Participants were asked about institutional factors, specifically the use of resources that may be provided by health care providers and/or non-profit organizations. In total, 39% of participants (n = 15/38) had accessed one or more of these institutional resources. Participants most commonly reported accessing educational materials about FH to share with family members (37%; Table 3 ). Other accessed resources included a health care provider's assistance making a plan for notifying family members (16%), speaking with a genetic counselor (8%), organizations and/or support groups for patients and families affected by FH (5%), and a health care provider's assistance in drafting a family letter about the risk of FH (3%).
Community/Public Policy Factors
The most commonly endorsed concern relating to community or public policy factors was insurance costs. Anticipated increase in health insurance costs for the participant or family members based on the familial risk of FH was a concern for 37% (n = 14). A subset of these participants also reported concerns about other insurance costs (29%, n = 11) and concern for a risk of discrimination from employers (13%, n = 5).
Statistical Analyses
Exploratory statistical tests did not yield significant differences (p < .05) between families with notification (those with at least one grandparent or aunt/uncle who had been notified) and families without known notification. Specifically, no differences were found between the two groups for responses to individual survey items, number of endorsed intrapersonal and interpersonal reasons for notification, number of endorsed intrapersonal and interpersonal barriers to notification, number of endorsed community/public policy concerns, or number of resources accessed.
Discussion
In order to maximize detection of FH cases using cascade screening, family notification must be optimized. As a prerequisite to such efforts, we present what are, to our knowledge, 
Notification and Screening of Family Members
This study assessed the extent of notification and testing in families of 38 children with FH from a single cardiology clinic. If cascade screening is occurring, one would expect screening of probands' parents. In this study, the majority of probands (76%) had a parent who had been diagnosed with FH, less than the expected 100%. This identification rate could have been reduced by incomplete participation in parental screening, which was observed here to be similar to a childparent cascade screening program in the UK (Wald et al. 2016 ). Among tested parents, there was a 56% diagnosis rate, comparable to the expected 50% diagnostic rate among firstdegree relatives. Most families reported notification and testing out to second-degree relatives. Notification of at least one of the proband's living grandparents and aunts/uncles was reported by 76 and 71%, respectively. FH testing of at least one grandparent and aunt/uncle was reported by 75 and 61%, respectively. These participation levels are comparable to those reported in a recent US study of adult women with FH, where 63% had a relative tested for FH (Benson et al. 2016) . Similarly, in a cascade program in the UK, most of the adult index cases (~70%) participated in family tracing facilitated by nurses, and most of the contacted relatives (~76%) agreed to testing (Hadfield et al. 2009 ). By comparison, the participation rate reached 90% in the Netherlands cascade program (Besseling et al. 2015) , suggesting that organized programs with extensive interventions may support higher levels of participation. Moving forward, there is a need for studies in the USA that review complete family histories to determine the proportion of relatives who were notified, as has been done within organized cascade programs and in intervention studies (Besseling et al. 2015; Hodgson et al. 2016) .
From a public health standpoint, far-reaching family notification can boost total detection of FH cases while reducing the need to identify index patients (Morris et al. 2012 ). In the current study, notification and/or testing rates declined from the probands' parents to siblings to grandparents to aunts/uncles. This trend suggests less communication about FH occurs with more distant relatives and that support from health care providers may be necessary to increase the extent of notification as recommended by the US Centers for Disease Control and Prevention.
The acceptability of indirect contact reported here by a majority of participants (68%) is consistent with results from studies of adult index patients (Hallowell et al. 2011 ) and surveys of the general population Maxwell et al. 2009 ). Yet, high acceptability of direct contact has also been observed in existing cascade programs and surveys of the general population (Maxwell et al. 2009; Newson and Humphries 2005; van Maarle et al. 2001) , and interview studies have found some index patients' desire assistance notifying relatives from health care providers or want to transfer responsibility (Hardcastle et al. 2015; van den Nieuwenhoff et al. 2007 ). The 2015 scientific statement on FH by the American Heart Association suggests that dual direct and indirect contact may be effective (Gidding et al. 2015) . Therefore, we speculate that for the 26% of our sample who stated Bno preference^between direct and indirect notification, increased assistance from health care providers might be appropriate (Sturm 2016) .
Recommendations Based on Intrapersonal and Interpersonal Factors
Intrapersonal factors are individual characteristics that influence notification. Previous studies have found that positive factors reported by adult FH patients include feeling a moral duty and wanting to protect relatives from physical harm (van den Nieuwenhoff et al. 2007; Weiner and Durrington 2008) . Negative factors include not feeling responsibility, wanting to protect relatives from psychological distress, insufficient knowledge of hereditary risk, and feeling little control over relatives' health behaviors (Benson et al. 2016; Claassen et al. 2012; Hardcastle et al. 2015; Hollman et al. 2006; Jenkins et al. 2013; van den Nieuwenhoff et al. 2007; Weiner and Durrington 2008) .
In the present study, strong agreement was observed among participants regarding reasons for family notification: to protect family members from heart disease (87%) and to allow family members to make changes in lifestyle (76%). We suggest emphasizing these prevalent rationales in patient education materials, family notification letters, and counseling by providers to reinforce these motivations. Health care providers could also ask about patients' individual motivators to provide positive reinforcement.
Participants' interpersonal barriers included concerns about insufficient FH knowledge, inadequate contact with relatives, and perceived resistance to lifestyle changes. These findings are consistent with previous studies of adult index patients with FH and the general population Hardcastle et al. 2015; van den Nieuwenhoff et al. 2007) . In particular, insufficient information about inheritance pattern and health risks has been identified as a major barrier to family notification about FH and other genetic conditions (Benson et al. 2016; Gaff et al. 2007) . Interpersonal difficulties identified in previous studies of family communication of genetic risk for a variety of conditions also include discomfort talking about illness and lack of conducive timing (Gaff et al. 2007 ).
The heterogeneity in participants' identified barriers suggests that genetic counselors and other health professionals may need to help patients identify and address their individual barriers, rather than attempting a one-size-fits-all approach. For example, there is some evidence that cascade screening participation rates can be improved by genetic counseling that includes discussions of family tracing and notification strategies, follow-up review of notification progress, and/or direct notification with invitation to genetic counseling (Forrest et al. 2008; Hodgson et al. 2016; Suthers et al. 2006 ).
Recommendations Based on Institutional, Community, and Public Policy Factors
Previous work in other settings has identified institutional factors affecting family notification, including the availability of professional assistance to educate patients on hereditary risk and the need for medical and lifestyle management (George et al. 2015; Jenkins et al. 2013; Santos et al. 2015) . Promotion of patient support organizations and clinical registries such as the FH Foundation's CASCADE FH Registry in the USA can also aid family tracing and follow-up (Defesche 2010; O'Brien et al. 2014; Santos et al. 2015) . Community and public policy may be relevant if individuals are concerned about affordability of health, life, and/or disability insurance (Defesche 2010; George et al. 2015; Homsma et al. 2008; Molfenter et al. 2012 ). In the USA, privacy laws may also dictate the success of direct cascade screening notification (Andersen and Andersen 2016; George et al. 2015) .
Our results suggest parents of children seeing a cardiovascular specialist are not frequently accessing resources such as educational materials or a health care provider's assistance making a plan for notifying relatives. This is particularly of concern given that the population is biased due to a higher level of care at a specialty lipid clinic, which in the majority of cases may have met the patient's needs. Incorporation of genetic counseling interventions to increase access and use of educational and communication resources may facilitate increased notification. There are many different suggested facilitators and interventions to improve family notification (e.g., professional assistance with identifying family members at risk and/or drafting a family letter; electronic medical record prompts to health care providers; follow-up telephone calls to index patients to monitor notification progress). However, it is unclear whether supportive interventions would facilitate increased uptake of family member notification. We suggest further research to compare the levels of notification for patients seen in a primary care clinic to those seen at a specialty center, along with the screening and patient education practices in those settings. More research is also needed to gauge the characteristics of patients who desire particular forms of support and to test the differential effectiveness of these approaches in intervention studies.
Limitations
There are several limitations to this study. Although the response rate of 31% is similar to those of other studies of cascade screening for FH (Benson et al. 2016; Hallowell et al. 2011; Hardcastle et al. 2015) , demographics were not available for non-respondents. Thus, it is not possible to assess the extent to which the study sample is representative of the larger population of families affected by FH. Generalizability may also be limited given the recruitment of a convenience sample from a single specialty lipid clinic. Participants' responses may have been affected by demand characteristics of asking about topics such as notification, health behaviors, and moral obligation. The majority of respondents were female and only one parent completed the survey for each child. Notification rates could differ based upon the gender of the parent and notification may have been higher if both parents were represented in the analysis. The small sample size also may have prevented identification of statistically significant differences in barriers and facilitators endorsed in families with and without notification. Additional research is warranted to elucidate pedigrees in greater detail to look for associations between the proportion of relatives who are notified and the barriers and facilitators identified in the present study.
Conclusions
This study complements previous studies assessing the implementation of universal pediatric lipid screening (Dixon et al. 2014) and the extent of cascade screening for FH (Stempel et al. 2016) by providing the first data on factors influencing family notification of FH risk within a pediatric population in the USA. Our data also show that notification at least out to second-degree relatives occurred in most families. The barriers to notification identified in this study suggest a need for genetic counseling interventions and resources for families. Further, helping parents associate the prevalent motivations identified herein with their own personal plans to contact relatives-especially distal relativesmay be especially useful in maximizing the extent of notification within families.
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